Hemispherx BioPharma, Inc. (NYSEAMEX:HEB) Trades Up 5.45%, Velti Plc (NASDAQ:VELT) Sluggish with 0.01% drop
Northern, WI 04/24/2013 (GDPInsider) – Hemispherx BioPharma, Inc. (NYSEAMEX:HEB) opened trading today at $0.21 and quickly made a rise. The stock is currently trading up at 5.45% with a range of $0.21 and $0.24. The pharmaceutical company has a market cap of $36.69 million and is presently trading 7.85% above its 50-day moving average and 7.90% above its 20-day moving average. The stock is down 78.76% on its 52-week high of 1.10 and up 29.78% on its 52-week low. There are 166.78 million shares outstanding and insiders own 0.51% of the stock in HEB. Sales have risen quarter on quarter by 39.47% but despite this consistency, analysts expect the EPS this year to decline by 84.89%.
HEB as recently as March 4, 2013 announced the introduction of Alferon N Injection into Argentina, having received regulatory approval from the country’s administrator of drugs. The introduction of Alferon in Argentina will help the nation’s 800,000 people who suffer from Hepatitis C and this is seen by many analysts as solid move on the part of the company. The stock has been trading relatively flat since March but there has a modest northward climb beginning in April. HEB currently has a RSI of 61.17.
Is HEB a solid investment at these levels? Get exclusive data and trends here.
Velti Plc (NASDAQ:VELT) opened trading today at $1.63 and is trading down just 0.01%. The trading range for the stock is $1.59 and $1.63 and volume stands at 564.49K. The stock is down 87.41% on its 52-week high of $12.79 and up 5.23% on its 52-week low of $1.53. Analysts have set a target price for the stock at $3.79 and EPS this year is expected to rise by 33.40%. There are 66.12 million shares outstanding and insiders account for 5.33% of share ownership. Institutions own 55.94% of the shares and the company has a gross margin of 58.67%. Sales have risen quarter on quarter by 63.38% and the company has a debt/equity ratio of 0.18.
The company was in the news recently after it announced a partnership with [x+1] to bring its mobile marketing and advertising technology to many customers of [x+1]. With mobile tipped as a general growth sector, the partnership is expected to yield solid long term benefits for Velti. Velti’s regional VP, Niles Lichtenstein, believes that the reach of mobile and the accompanying technologies represents a crucial part of the marketing mix.
How Should Investors Trade VELT Now? Get exclusive insights and updates here.